Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hannah Cummings"'
Autor:
Michael J. Doane, Leona Bessonova, Haley S. Friedler, Kathleen M. Mortimer, Harry Cheng, Thomas Brecht, Amy K. O’Sullivan, Hannah Cummings, David McDonnell, Jonathan M. Meyer
Publikováno v:
BMC Psychiatry, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Many second-generation antipsychotics (SGAs) are associated with weight gain and cardiometabolic effects. Antipsychotic-associated weight gain is linked to treatment interruptions, potentially increasing risk of relapse and hospit
Externí odkaz:
https://doaj.org/article/2eccad05e5a7416594f176979e2a24dc
Autor:
Roger S. Mcintyre, Leslie Citrome, Hannah Cummings, Mark S. Todtenkopf, Laura A. Tan, Marni White, Sarah Akerman
Publikováno v:
CNS spectrums.
Background The endogenous opioid system affects metabolism, including weight regulation. Evidence from preclinical and clinical studies provides a rationale for targeting this system to mitigate weight-related side effects of antipsychotics. This rev
An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder
Autor:
Christine Graham, Adam Simmons, Bernard L. Silverman, Ying Jiang, David McDonnell, Hannah Cummings, Leslie Citrome, Lei Sun, Mark S. Todtenkopf, Lauren DiPetrillo
Publikováno v:
Neuropsychiatric Disease and Treatment
Olanzapine effectively treats schizophrenia and bipolar I disorder (BD-I); however, its use is limited by the risk of significant weight gain and metabolic effects. OLZ/SAM, a combination of olanzapine and samidorphan, was recently approved in the Un
Autor:
Mark S. Todtenkopf, Hannah Cummings, David McDonnell, Bernard L. Silverman, Lei Sun, Ying Jiang, Leslie Citrome, Lauren DiPetrillo, Christine Graham, Adam Simmons
Publikováno v:
Neuropsychiatric Disease and Treatment. 17:3135-3136
Citrome L, Graham C, Simmons A, et al. Neuropsychiatr Dis Treat. 2021;17:2885–2904. The authors have advised there is an error in Figure 1C on page 2894. The key “OLZ/SAM” should read “Olanzapine + samidorphan 10 mg” and “Olanzapine” sh
Autor:
Roger S. McIntyre, Maria A. Sullivan, Laura Tan, Leslie Citrome, Mark S. Todtenkopf, Hannah Cummings, Marni White, Sarah C. Akerman
Publikováno v:
Biological Psychiatry. 89:S295
Autor:
Adam Simmons, Lauren DiPetrillo, Christine Graham, Hannah Cummings, Mark S. Todtenkopf, Bernard L. Silverman, David McDonnell, Leslie Citrome, Lei Sun, Ying Jiang
Publikováno v:
CNS Spectrums. 26:170-170
ObjectivesOlanzapine effectively treats schizophrenia and bipolar I disorder (BD-I); however, its use is hindered by significant weight gain. A combination of olanzapine and samidorphan (OLZ/SAM) is in development to provide the efficacy of olanzapin
Autor:
Harry Cheng, Michael J. Doane, Thomas Brecht, Leona Bessonova, Amy K O'Sullivan, Gregory Donadio, Kathleen M. Mortimer, Jonathan M. Meyer, Hannah Cummings, David McDonnell
Publikováno v:
CNS Spectrums. 26:160-160
Among patients with schizophrenia (SZ) and bipolar I disorder (BD-I) treated with second-generation antipsychotics (SGAs), clinically-significant weight gain (CSWG) and treatment interruptions (TIs) are challenges that may result in morbidity/mortali
Publikováno v:
Journal of Allergy and Clinical Immunology. 133:AB76